Apyx Medical Corporation (APYX)
USD 0.94
(-4.52%)
USD 0.94
(-4.52%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 38.5 Million USD | 4736.81% |
| 2022 | 796 Thousand USD | 160.98% |
| 2021 | 305 Thousand USD | -54.88% |
| 2020 | 676 Thousand USD | -40.34% |
| 2019 | 1.13 Million USD | 709.29% |
| 2018 | 140 Thousand USD | -95.06% |
| 2017 | 2.83 Million USD | -7.78% |
| 2016 | 3.07 Million USD | -7.24% |
| 2015 | 3.31 Million USD | -2.9% |
| 2014 | 3.41 Million USD | 4.76% |
| 2013 | 3.25 Million USD | -4.74% |
| 2012 | 3.41 Million USD | -18.9% |
| 2011 | 4.21 Million USD | 4.77% |
| 2010 | 4.02 Million USD | -20.99% |
| 2009 | 5.09 Million USD | 27.33% |
| 2008 | 4 Million USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 161.94 Thousand USD | -53.51% |
| 2005 | 348.32 Thousand USD | -8.33% |
| 2004 | 379.99 Thousand USD | -8.51% |
| 2003 | 415.33 Thousand USD | -57.13% |
| 2002 | 968.79 Thousand USD | 44.1% |
| 2001 | 672.3 Thousand USD | 17.35% |
| 2000 | 572.93 Thousand USD | -13.66% |
| 1999 | 663.57 Thousand USD | 14.33% |
| 1998 | 580.41 Thousand USD | -33.96% |
| 1997 | 878.86 Thousand USD | 28.25% |
| 1996 | 685.3 Thousand USD | -15.52% |
| 1995 | 811.2 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 38.7 Million USD | 0.2% |
| 2024 Q1 | 38.62 Million USD | 0.32% |
| 2023 Q2 | 14.41 Million USD | 51.54% |
| 2023 Q4 | 38.5 Million USD | 167.57% |
| 2023 Q1 | 9.51 Million USD | 1094.85% |
| 2023 FY | 38.5 Million USD | 4736.81% |
| 2023 Q3 | 14.38 Million USD | -0.17% |
| 2022 Q1 | 218 Thousand USD | -28.52% |
| 2022 Q2 | 802 Thousand USD | 267.89% |
| 2022 Q3 | 814 Thousand USD | 1.5% |
| 2022 Q4 | 796 Thousand USD | -2.21% |
| 2022 FY | 796 Thousand USD | 160.98% |
| 2021 Q4 | 305 Thousand USD | -22.78% |
| 2021 FY | 305 Thousand USD | -54.88% |
| 2021 Q1 | 558 Thousand USD | -17.46% |
| 2021 Q2 | 491 Thousand USD | -12.01% |
| 2021 Q3 | 395 Thousand USD | -19.55% |
| 2020 Q1 | 1.04 Million USD | -7.77% |
| 2020 Q2 | 1.1 Million USD | 6.12% |
| 2020 Q3 | 1.02 Million USD | -7.39% |
| 2020 Q4 | 676 Thousand USD | -34.18% |
| 2020 FY | 676 Thousand USD | -40.34% |
| 2019 FY | 1.13 Million USD | 709.29% |
| 2019 Q4 | 1.13 Million USD | 0.35% |
| 2019 Q3 | 1.12 Million USD | 177.4% |
| 2019 Q2 | 407 Thousand USD | 89.3% |
| 2019 Q1 | 215 Thousand USD | 53.57% |
| 2018 Q1 | 2.77 Million USD | -2.12% |
| 2018 FY | 140 Thousand USD | -95.06% |
| 2018 Q4 | 140 Thousand USD | 0.0% |
| 2018 Q3 | 140 Thousand USD | -94.84% |
| 2018 Q2 | 2.71 Million USD | -2.16% |
| 2017 Q2 | 2.95 Million USD | -1.99% |
| 2017 Q3 | 2.89 Million USD | -2.03% |
| 2017 Q4 | 2.83 Million USD | -2.07% |
| 2017 FY | 2.83 Million USD | -7.78% |
| 2017 Q1 | 3.01 Million USD | -1.92% |
| 2016 FY | 3.07 Million USD | -7.24% |
| 2016 Q1 | 3.25 Million USD | -1.81% |
| 2016 Q2 | 3.19 Million USD | -1.84% |
| 2016 Q3 | 3.13 Million USD | -1.88% |
| 2016 Q4 | 3.07 Million USD | -1.92% |
| 2015 FY | 3.31 Million USD | -2.9% |
| 2015 Q3 | 3.23 Million USD | -1.79% |
| 2015 Q2 | 3.29 Million USD | -1.79% |
| 2015 Q1 | 3.35 Million USD | -1.76% |
| 2015 Q4 | 3.31 Million USD | 2.47% |
| 2014 Q4 | 3.41 Million USD | -1.7% |
| 2014 Q3 | 3.47 Million USD | -1.73% |
| 2014 Q2 | 3.53 Million USD | -1.67% |
| 2014 FY | 3.41 Million USD | 4.76% |
| 2014 Q1 | 3.59 Million USD | 10.29% |
| 2013 Q1 | 3.38 Million USD | -0.99% |
| 2013 Q3 | 3.31 Million USD | -1.04% |
| 2013 Q4 | 3.25 Million USD | -1.78% |
| 2013 FY | 3.25 Million USD | -4.74% |
| 2013 Q2 | 3.35 Million USD | -1.0% |
| 2012 Q4 | 3.41 Million USD | -8.92% |
| 2012 FY | 3.41 Million USD | -18.9% |
| 2012 Q1 | 3.93 Million USD | -6.67% |
| 2012 Q2 | 506 Thousand USD | -87.14% |
| 2012 Q3 | 3.75 Million USD | 641.9% |
| 2011 Q2 | 3.78 Million USD | -0.92% |
| 2011 FY | 4.21 Million USD | 4.77% |
| 2011 Q4 | 4.21 Million USD | 12.52% |
| 2011 Q3 | 3.74 Million USD | -0.93% |
| 2011 Q1 | 3.81 Million USD | -5.14% |
| 2010 Q1 | 5.05 Million USD | -0.66% |
| 2010 FY | 4.02 Million USD | -20.99% |
| 2010 Q3 | 3.77 Million USD | -0.89% |
| 2010 Q4 | 4.02 Million USD | 6.63% |
| 2010 Q2 | 3.8 Million USD | -24.74% |
| 2009 Q2 | 5.2 Million USD | 22.86% |
| 2009 FY | 5.09 Million USD | 27.33% |
| 2009 Q3 | 5.17 Million USD | -0.59% |
| 2009 Q4 | 5.09 Million USD | -1.58% |
| 2009 Q1 | 4.23 Million USD | 5.92% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | 4 Million USD | 40.35% |
| 2008 FY | 4 Million USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | 2.85 Million USD | 0.0% |
| 2007 Q1 | 400 Thousand USD | 146.99% |
| 2007 FY | - USD | -100.0% |
| 2007 Q2 | 400 Thousand USD | 0.0% |
| 2007 Q3 | 400 Thousand USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2006 Q1 | 370.41 Thousand USD | 6.34% |
| 2006 Q2 | 185.84 Thousand USD | -49.83% |
| 2006 Q3 | 203.24 Thousand USD | 9.36% |
| 2006 FY | 161.94 Thousand USD | -53.51% |
| 2006 Q4 | 161.94 Thousand USD | -20.32% |
| 2005 Q3 | 356.24 Thousand USD | -2.17% |
| 2005 Q4 | 348.32 Thousand USD | -2.22% |
| 2005 Q2 | 364.16 Thousand USD | 1049.94% |
| 2005 Q1 | 31.66 Thousand USD | -91.67% |
| 2005 FY | 348.32 Thousand USD | -8.33% |
| 2004 Q2 | 31.66 Thousand USD | 0.0% |
| 2004 Q1 | 31.66 Thousand USD | -92.38% |
| 2004 Q4 | 379.99 Thousand USD | 1099.93% |
| 2004 Q3 | 31.66 Thousand USD | 0.0% |
| 2004 FY | 379.99 Thousand USD | -8.51% |
| 2003 FY | 415.33 Thousand USD | -57.13% |
| 2003 Q1 | 1.11 Million USD | 15.09% |
| 2003 Q4 | 415.33 Thousand USD | -5.05% |
| 2003 Q3 | 437.42 Thousand USD | 31.61% |
| 2003 Q2 | 332.37 Thousand USD | -70.19% |
| 2002 Q2 | 445.03 Thousand USD | 39.49% |
| 2002 Q4 | 968.79 Thousand USD | 78.69% |
| 2002 FY | 968.79 Thousand USD | 44.1% |
| 2002 Q3 | 542.18 Thousand USD | 21.83% |
| 2002 Q1 | 319.05 Thousand USD | -52.54% |
| 2001 FY | 672.3 Thousand USD | 17.35% |
| 2001 Q1 | 585.23 Thousand USD | 2.15% |
| 2001 Q2 | 851.1 Thousand USD | 45.43% |
| 2001 Q3 | 805.19 Thousand USD | -5.39% |
| 2001 Q4 | 672.3 Thousand USD | -16.5% |
| 2000 Q4 | 572.93 Thousand USD | -5.57% |
| 2000 Q1 | 590.42 Thousand USD | -1.6% |
| 2000 FY | 572.93 Thousand USD | -13.66% |
| 2000 Q3 | 606.72 Thousand USD | -11.98% |
| 2000 Q2 | 689.28 Thousand USD | 16.74% |
| 1999 FY | 663.57 Thousand USD | 14.33% |
| 1999 Q1 | 600 Thousand USD | 0.0% |
| 1999 Q2 | 500 Thousand USD | -16.67% |
| 1999 Q3 | 500 Thousand USD | 0.0% |
| 1999 Q4 | 600 Thousand USD | 20.0% |
| 1998 Q1 | 800 Thousand USD | -11.11% |
| 1998 Q2 | 3.9 Million USD | 387.5% |
| 1998 Q3 | 600 Thousand USD | -84.62% |
| 1998 Q4 | 600 Thousand USD | 0.0% |
| 1998 FY | 580.41 Thousand USD | -33.96% |
| 1997 Q2 | 900 Thousand USD | 0.0% |
| 1997 Q1 | 900 Thousand USD | 28.57% |
| 1997 Q4 | 900 Thousand USD | -10.0% |
| 1997 FY | 878.86 Thousand USD | 28.25% |
| 1997 Q3 | 1 Million USD | 11.11% |
| 1996 Q2 | 700 Thousand USD | -12.5% |
| 1996 FY | 685.3 Thousand USD | -15.52% |
| 1996 Q3 | 700 Thousand USD | 0.0% |
| 1996 Q1 | 800 Thousand USD | 0.0% |
| 1996 Q4 | 700 Thousand USD | 0.0% |
| 1995 Q4 | 800 Thousand USD | 0.0% |
| 1995 FY | 811.2 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CVRx, Inc. | 30.61 Million USD | -25.767% |
| electroCore, Inc. | 626 Thousand USD | -6050.319% |
| Inogen, Inc. | 21.92 Million USD | -75.619% |
| OrthoPediatrics Corp. | 23.76 Million USD | -62.041% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -152.383% |
| Spectral AI, Inc. | 1.28 Million USD | -2886.889% |
| MaxCyte, Inc. | 18.74 Million USD | -105.415% |
| PAVmed Inc | 48.72 Million USD | 20.983% |
| Sight Sciences, Inc. | 35.41 Million USD | -8.717% |
| SI-BONE, Inc. | 38.99 Million USD | 1.259% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -10333.875% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -2313.856% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -1829.875% |
| Acutus Medical, Inc. | 38.47 Million USD | -0.057% |
| Nemaura Medical Inc. | 20.03 Million USD | -92.215% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -2720.503% |
| Talis Biomedical Corporation | 19.66 Million USD | -95.755% |
| Viveve Medical, Inc. | 5.34 Million USD | -619.779% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -424.108% |
| BrainsWay Ltd. | 471 Thousand USD | -8074.31% |
| Quanterix Corporation | 41.46 Million USD | 7.146% |
| IceCure Medical Ltd | 599 Thousand USD | -6327.546% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -1153.671% |
| RxSight, Inc. | 3.01 Million USD | -1178.254% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -358.564% |
| Nexalin Technology, Inc. | 4463.00 USD | -862570.849% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -1828.425% |
| Orthofix Medical Inc. | 134.19 Million USD | 71.311% |
| NanoVibronix, Inc. | 5000.00 USD | -769920.0% |
| TELA Bio, Inc. | 42.78 Million USD | 10.002% |
| Biotricity, Inc. | 23.87 Million USD | -61.235% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 1.833% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -7725.55% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -3994.475% |
| Venus Concept Inc. | 79.69 Million USD | 51.691% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -67445.614% |
| Bioventus Inc. | 409.47 Million USD | 90.597% |
| Cerus Corporation | 95.99 Million USD | 59.894% |
| Envoy Medical, Inc. | 404 Thousand USD | -9429.95% |
| LivaNova PLC | 640.4 Million USD | 93.988% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 45.236% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -20779.067% |
| 908 Devices Inc. | 5.94 Million USD | -547.62% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 92.892% |
| NeuroPace, Inc. | 72.39 Million USD | 46.818% |
| LENSAR, Inc. | 2.3 Million USD | -1567.432% |
| Cutera, Inc. | 431.91 Million USD | 91.086% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -146.28% |
| BioSig Technologies, Inc. | 452 Thousand USD | -8417.92% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -32.593% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -176.171% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 97.711% |
| Axonics, Inc. | 27.61 Million USD | -39.411% |
| Outset Medical, Inc. | 136.18 Million USD | 71.73% |
| IRIDEX Corporation | 2.74 Million USD | -1302.076% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 51.39% |
| IRadimed Corporation | 2.04 Million USD | -1784.493% |
| INVO Bioscience, Inc. | 8.68 Million USD | -343.378% |
| Telesis Bio, Inc. | 34.38 Million USD | -11.987% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -274.845% |
| Varex Imaging Corporation | 469.5 Million USD | 91.8% |
| Quipt Home Medical Corp. | 98.94 Million USD | 61.088% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1539.736% |
| Pulmonx Corporation | 41.42 Million USD | 7.056% |
| Dynatronics Corporation | 6.68 Million USD | -475.677% |
| Modular Medical, Inc. | 1.19 Million USD | -3135.378% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -14595.038% |
| Semler Scientific, Inc. | 70 Thousand USD | -54901.429% |
| InMode Ltd. | 9.01 Million USD | -326.982% |
| Bruker Corporation | 1.37 Billion USD | 97.209% |
| Cytosorbents Corporation | 18.31 Million USD | -110.237% |
| DexCom, Inc. | 2.59 Billion USD | 98.516% |
| Align Technology, Inc. | 96.96 Million USD | 60.295% |
| ZimVie Inc. | 521.92 Million USD | 92.623% |
| Movano Inc. | 252 Thousand USD | -15178.175% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -16.058% |
| Nexalin Technology, Inc. | 4463.00 USD | -862570.849% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -1828.425% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 90.738% |
| Profound Medical Corp. | 7.9 Million USD | -387.332% |
| Insulet Corporation | 1.44 Billion USD | 97.343% |
| enVVeno Medical Corporation | 1.4 Million USD | -2646.148% |
| Surmodics, Inc. | 29.4 Million USD | -30.934% |
| iCAD, Inc. | 461 Thousand USD | -8251.627% |
| Nuwellis, Inc. | 981 Thousand USD | -3824.669% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 70.344% |
| InspireMD, Inc. | 1.59 Million USD | -2313.856% |
| PAVmed Inc. | 48.72 Million USD | 20.983% |
| BIOLASE, Inc. | 17.91 Million USD | -114.969% |
| Beyond Air, Inc. | 17.83 Million USD | -115.849% |
| FONAR Corporation | 41.67 Million USD | 7.618% |
| AxoGen, Inc. | 69.29 Million USD | 44.437% |
| Vivani Medical, Inc. | 20.69 Million USD | -86.031% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 23.571% |
| Inari Medical, Inc. | 32.04 Million USD | -20.139% |
| UFP Technologies, Inc. | 46.03 Million USD | 16.369% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -3615.101% |
| Tenon Medical, Inc. | 1.17 Million USD | -3182.268% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -3742.415% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -1187.415% |
| AdaptHealth Corp. | 2.29 Billion USD | 98.322% |
| Sintx Technologies, Inc. | 4.24 Million USD | -806.973% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1539.736% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -4817.114% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 95.878% |
| TransMedics Group, Inc. | 515.94 Million USD | 92.538% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -1923.174% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -15883.743% |
| Hyperfine, Inc. | 185 Thousand USD | -20711.351% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 79.971% |
| Biomerica, Inc. | 785 Thousand USD | -4804.586% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -8465.619% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -10302.724% |
| Silk Road Medical, Inc | 84.63 Million USD | 54.508% |